Walleye Capital’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.72M Buy
187,213
+154,162
+466% +$6.71M 0.01% 1474
2026
Q2
$1.41M Buy
33,051
+28,633
+648% +$1.28M 0.01% 1822
2026
Q1
$213K Buy
4,418
+4,417
+441,700% +$206K ﹤0.01% 3311
2025
Q4
$48 Sell
1
-54,144
-100% -$2.68M ﹤0.01% 4450
2025
Q3
$2.56M Buy
+54,145
New +$2.61M 0.01% 1392
2025
Q2
– Sell
-39,415
Closed -$2.01M – 5005
2025
Q1
$2.19M Buy
39,415
+29,717
+306% +$1.61M 0.01% 1345
2024
Q4
$468K Sell
9,698
-44,425
-82% -$2.26M ﹤0.01% 3044
2024
Q3
$3.12M Buy
54,123
+39,525
+271% +$2.13M 0.01% 1551
2024
Q2
$708K Buy
14,598
+6,532
+81% +$315K ﹤0.01% 3176
2024
Q1
$392K Sell
8,066
-90,688
-92% -$4.43M ﹤0.01% 3416
2023
Q4
$4.91M Sell
98,754
-76,081
-44% -$3.72M 0.01% 1126
2023
Q3
$9.38M Buy
+174,835
New +$9.32M 0.02% 610
2018
Q3
$981K Buy
+21,953
New +$938K 0.46% 64

Other funds holding SNY

Walleye Capital's SNY Position: Q3 2026 in Review

Walleye Capital increased its Sanofi (SNY) stake by 466% in Q3 2026, buying an estimated $6.71M and bringing the position to 187,213 shares worth $7.72M. The position accounts for 0.01% of the portfolio, ranked #1474.

Walleye Capital first reported a position in SNY in Q3 2018 and has held it in 13 quarters since. The position peaked at $9.38M in Q3 2023. 577 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Walleye Capital held 187,213 shares of Sanofi worth $7.72M as of Q3 2026.
  • Walleye Capital bought 154,162 Sanofi shares in Q3 2026, an estimated $6.71M.
  • Sanofi made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #1474 holding.
  • Walleye Capital first reported a position in Sanofi in Q3 2018 and has held it in 13 quarters since.
  • Walleye Capital's Sanofi position peaked at $9.38M in Q3 2023.
  • 577 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.